UY30536A1 - SYSTEM OF CONTROLLED PHARMACEUTICAL RELEASE, PARTICULARLY ORAL ADMINISTRATION OF ACTIVE SUBSTANCES WITH SOLUBILITIES OF PH, PREPARATION AND APPLICATION. - Google Patents

SYSTEM OF CONTROLLED PHARMACEUTICAL RELEASE, PARTICULARLY ORAL ADMINISTRATION OF ACTIVE SUBSTANCES WITH SOLUBILITIES OF PH, PREPARATION AND APPLICATION.

Info

Publication number
UY30536A1
UY30536A1 UY30536A UY30536A UY30536A1 UY 30536 A1 UY30536 A1 UY 30536A1 UY 30536 A UY30536 A UY 30536A UY 30536 A UY30536 A UY 30536A UY 30536 A1 UY30536 A1 UY 30536A1
Authority
UY
Uruguay
Prior art keywords
solubilities
active substances
preparation
application
oral administration
Prior art date
Application number
UY30536A
Other languages
Spanish (es)
Inventor
Florian Sommer
Farl G Wagner
Thomas Friedl
Nantharat Pearnchob
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Priority to UY30536A priority Critical patent/UY30536A1/en
Publication of UY30536A1 publication Critical patent/UY30536A1/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

Sistema de liberacion farmacéutica controlada (independiente del pH) para administracion, particularmente oral, de sustancias activas con solubilidades dependientes del pH, comprendiendo material de nucleo conteniendo o consistiendo en uno o más modificadores del pH farmacéuticamente aceptables y las siguientes capas: a) opcionalmente una aislante, c) una primera comprendiendo uno o más polímeros insolubles en agua farmacéuticamente aceptables; d) una segunda comprendiendo por lo menos una sustancia activa con una solubilidad dependiente del pH; e) una tercera comprendiendo uno o más polímeros farmacéuticamente aceptables conteniendo grupos anionicos o no ionicos; y f) opcionalmente una cuarta, preferiblemente en forma de recubrimiento externo.Pharmaceutical controlled release system (independent of pH) for administration, particularly oral, of active substances with pH-dependent solubilities, comprising core material containing or consisting of one or more pharmaceutically acceptable pH modifiers and the following layers: a) optionally a insulator, c) a first comprising one or more pharmaceutically acceptable water insoluble polymers; d) a second one comprising at least one active substance with a pH dependent solubility; e) a third comprising one or more pharmaceutically acceptable polymers containing anionic or non-ionic groups; and f) optionally a fourth, preferably in the form of an external coating.

UY30536A 2007-08-13 2007-08-13 SYSTEM OF CONTROLLED PHARMACEUTICAL RELEASE, PARTICULARLY ORAL ADMINISTRATION OF ACTIVE SUBSTANCES WITH SOLUBILITIES OF PH, PREPARATION AND APPLICATION. UY30536A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UY30536A UY30536A1 (en) 2007-08-13 2007-08-13 SYSTEM OF CONTROLLED PHARMACEUTICAL RELEASE, PARTICULARLY ORAL ADMINISTRATION OF ACTIVE SUBSTANCES WITH SOLUBILITIES OF PH, PREPARATION AND APPLICATION.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UY30536A UY30536A1 (en) 2007-08-13 2007-08-13 SYSTEM OF CONTROLLED PHARMACEUTICAL RELEASE, PARTICULARLY ORAL ADMINISTRATION OF ACTIVE SUBSTANCES WITH SOLUBILITIES OF PH, PREPARATION AND APPLICATION.

Publications (1)

Publication Number Publication Date
UY30536A1 true UY30536A1 (en) 2008-03-31

Family

ID=39247293

Family Applications (1)

Application Number Title Priority Date Filing Date
UY30536A UY30536A1 (en) 2007-08-13 2007-08-13 SYSTEM OF CONTROLLED PHARMACEUTICAL RELEASE, PARTICULARLY ORAL ADMINISTRATION OF ACTIVE SUBSTANCES WITH SOLUBILITIES OF PH, PREPARATION AND APPLICATION.

Country Status (1)

Country Link
UY (1) UY30536A1 (en)

Similar Documents

Publication Publication Date Title
AR062321A1 (en) CONTROLLED RELEASE SYSTEM AND METHOD TO MANUFACTURE
CY2019021I1 (en) DRUG DELIVERY SYSTEM FOR THE DELIVERY OF POORLY WATER-SOLUBLE PHARMACEUTICALLY ACTIVE SUBSTANCES
WO2008146178A3 (en) A novel tablet dosage form
CL2011000170A1 (en) Solid and stabilized pharmaceutical composition comprising a pharmaceutically active ingredient, titanium oxide and a plasticizer; procedure to stabilize the pharmaceutical composition during a light irradiation.
CU20080052A7 (en) SOLID PHARMACEUTICAL PRESENTATION FORMS OF ORAL ADMINISTRATION WITH QUICK RELEASE OF ACTIVE PRINCIPLE
CL2011002968A1 (en) Hot melt extrusion dosage form of an active ingredient (a) included in a matrix comprising a polymer (c), the core having a morphological orientation orthogonal to the longitudinal direction of extension of the dosage form; and its preparation procedure.
WO2009032034A3 (en) Stabilized picoplatin dosage form
CL2012001404A1 (en) Pharmaceutical composition comprising drug-coated compressible microparticles, a taste-masking, modified-release coating comprising a water-insoluble polymer and a compressible coating with a non-polymeric sweetener thereon; composition of orally rapidly disintegrating tablets; Preparation method.
WO2009066146A3 (en) Stable solutions of sparingly soluble actives
CY1118032T1 (en) PROCESSES FOR COMMERCIAL PREPARATION OF PHARMACEUTICAL ACTIVE AGENT
NZ594311A (en) Pharmaceutical composition comprising tamsulosin and solifenacin for oral administration
CY1116831T1 (en) USE 24-norUDCA
ECSP14010605A (en) SYSTEM FOR THE ADMINISTRATION OF DRUGS
UY31452A1 (en) IMPROVED TABLET COATING
EP3858846A4 (en) Nucleic acid nanocarrier medicament, preparation method therefor, pharmaceutical composition thereof, and use thereof
WO2009107136A3 (en) Drug delivery device, system and method
NO20091467L (en) Pharmaceutical formulations comprising clopidogrel
WO2012111996A3 (en) Transdermal delivery system containing galantamine or salts thereof
RU2007136310A (en) METHOD FOR PRODUCING NANOSIZED SYSTEM OF DELIVERY OF MEDICINES BASED ON SILICON DIOXIDE
ECSP109871A (en) ORAL PHARMACEUTICAL SOLUTIONS CONTAINING TELBIVUDINE
ECSP099251A (en) PHARMACEUTICAL FORMULATIONS
ES2531241T3 (en) Trazodone-based stable liquid pharmaceutical composition
UY30536A1 (en) SYSTEM OF CONTROLLED PHARMACEUTICAL RELEASE, PARTICULARLY ORAL ADMINISTRATION OF ACTIVE SUBSTANCES WITH SOLUBILITIES OF PH, PREPARATION AND APPLICATION.
AR059225A1 (en) CITRATE SALT, PREPARATION PROCESS AND ITS ACTIVITY IN THERAPY
MA31227B1 (en) PHARMACEUTICAL COMPOSITION COMPRISING PHLOROGLUCINOL AND PARACETAMOL.

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20170725